Skip to content Skip to footer

Main Topics

  • One-health approach: behind human and animal medicine, microbiome research in agriculture and bioeconomy
  • The impact of zoonosis on human microbiome and clinical outcome
  • Environmental Stressors on the Gut Microbiota
  • Evolutionary perspective of human microbiome (the ancestral microbiome)
  • The epigenetic influence of the microbiome in human health
  • The forgotten members of the microbiome – mycobiome, virome, archaeome, parasitome
  • Environmental microbiota and human health (including soil or water microbiota in agriculture)
  • Environmental pollution and its impact on human microbiome changes dictating the balance between health and disease
  • How macro-scale events (including wars, displacement and migration, refugee camps, pandemics) may impact human microbiome and clinical outcomes
  • Direct impacts of other microbiomes on the human microbiome and health in relation to antimicrobial resistance, pathogenicity, emerging pathogens
  • The host microbiomes: role of domestication and breeding activities
  • Computational biology and metagenomics and other omics (metabolomics, glycomic, proteomic, etc)
  • Methodology of human microbiome studies
  • How informatics, big data management and modeling through AI will capitalize on microbiota studies for personalized medicine and primary prevention
  • Pre-clinical models, their challenges, and the translation gap
  • Accelerating human microbiome interventions – regulatory/safety issues and production challenges with novel (non-QPS) organisms
  • Impact of host genetics on the gut microbiome engraftment and maturation
  • The first 1000 days of life: from pregnancy to infancy in health and disease
  • The impact of a maternal diet during pregnancy on the developing microbiome
  • Microbiome and Breastfeeding
  • Bifidogenic effect: is this a microbiological or a clinical effect
  • The strength of prospective cohorts in mechanistically linking microbiota composition and function to disease pathogenesis
  • Microbiome and Breastfeeding
  • Personalized Nutrition and Gut Microbiota
  • Microbiota and food safety
  • Microbial interaction with plants and agricultural crops
  • Food-associated microbiota
  • Microbiome friendly healthy diets
  • Microbiome and Ultraprocessed Foods: fertilisers, pesticides, insecticides
  • Postbiotics in Malnutrition

General Aspects

  • Microbiome testings in clinical practice

  • The host microbiome in diagnosis, prevention and therapy

  • Microbiome and the gut-brain, gut-lung, gut-liver axes

  • Virome, mycobiome, archeome and parasitome in health and diseases

  • Microbiota in organs 

  • How does the microbiome contribute to disease onset and progression

  • Common intracellular pathways involved in ion transport effects, cell growth and inflammation induced by probiotics

  • Microbiome as pathogenic driver of GI and extra-GI diseases

  • Microbiota in pathological tissues (tumors, periodontitis)

  • Dysbiosis in Pediatrics

  • Leaky gut and dysbiosis

  • Methodology of human microbiome studies

Microbiome and Gastroenterological Diseases

  •  Inflammatory Bowel Diseases

  • Celiac disease

  • Liver diseases

  • Food allergies

  • Gastrointestinal cancer

  • Pancreatic diseases

  • Irritable bowel syndrome

  • Necrotizing enterocolitis

  • Environmental enteropathy

 Microbiome and Gut Brain Axis

  • Microbiota gut brain axis

  • Microbiome and Brain Development

  • Microbiome and neurodegenerative diseases (Parkinson, Alzheimer)

  • The impact of microbiota on aging, neurological diseases and mental health

Microbiome and Oncology

  • Oncobiome

  • The gut microbiome and its role in cancer

  • Role of the use of probiotics in the management of pediatric cancer

  • Pharmacomicrobiomics: drug-microbiota interactions in anticancer therapies

Microbiota and other diseases

  • Microbiome and autoimmune diseases

  • Microbiome and obesity

  • Relationship of microbiome and infections diseases/drug resistant microbes

  • Microbiome and metabolic disorders

  • Prebiotics, probiotics, symbiotic, postbiotics
  • Anti-Pre-pro-postbiotics
  • FMT and beyond (live biotherapeutics)
  • Microbial metabolomics (postbiotics)
  • Postbiotics in pediatric infectious diseases  
  • Phage therapy and other specific treatments
  • Synthetic biology
  • Effects of probiotics and postbiotics on oxidative stress in gastroenteritis
  • Effects of probiotics and postbiotics on oxidative stress in gastroenteritis
  • Common pathways involved in antidiarrheal effects by different probiotics
  • The needs of applying stringent “pharma” criteria to selected clinical effects rather than to strains: the case of necrotising enterocolitis
  • Measuring dose effects by living microorganisms in the intestine: an unresolved issue
  • Probiotics effects at the enterocyte surface: a topological perspective

How to Find Us

The new reference point
of the Directorial Rome

Organising Secretariat

Via Michele Mercati, 33
00197 Rome, Italy
Ph. +39.06.80693320

Send a Message

Contact us for any information we will be happy to answer you

IHMC2024 © All rights reserved.